Analytical Method Development, Transfer, and Validation

In modern pharmaceutical and biotechnology development, analytical methods serve as the scientific foundation for ensuring product quality, safety, and regulatory compliance. From early discovery through clinical development and commercial manufacturing, robust analytical methodologies are essential to accurately characterize drug substances and products, including identity, purity, potency, and stability.

Analytical method development, transfer, and validation collectively form a critical workflow that supports Chemistry, Manufacturing, and Controls (CMC) activities and regulatory submissions. These processes ensure that analytical data generated across laboratories and throughout the product lifecycle are reliable, reproducible, and compliant with global regulatory expectations such as ICH and FDA guidelines. At our company, a leading pharmaceutical development partner, we provide comprehensive analytical method development, transfer, and validation services tailored to meet the evolving needs of biotech startups, large pharmaceutical companies, and virtual organizations. Our integrated approach ensures that methods are scientifically sound, phase-appropriate, and ready for regulatory scrutiny at every stage of development.

Our Services

To support the full lifecycle of pharmaceutical and biopharmaceutical development, our analytical method development, transfer, and validation services are designed as an integrated, end-to-end solution. We ensure that analytical methods are not only fit for their intended purpose but also scalable and transferable across laboratories and development stages.

Analytical Method Development

Background

Analytical method development is the cornerstone of any successful drug development program. It involves designing and optimizing analytical procedures that can accurately and reliably measure critical quality attributes of a drug substance or product.

Methodology

Our scientists employ a fit-for-purpose strategy, ensuring that each method is tailored to the molecule type, development phase, and intended application. These methods support a wide range of activities including:

• Drug substance and drug product characterization
• Stability-indicating assays
• ...

• Impurity profiling and degradation studies
• Release and quality control testing

Using advanced analytical techniques such as LC-MS/MS, UPLC, NMR, and GC-MS, we optimize chromatographic conditions, detection parameters, and sample preparation workflows to achieve high sensitivity, specificity, and robustness. Moreover, we also integrate Quality by Design (QbD) principles into method development, enabling a deeper understanding of method variables and ensuring long-term robustness.

Deliverables include:

• Customized method development protocols
• Optimized analytical procedures
• Preliminary performance and robustness data
• Recommendations for validation and lifecycle management

Analytical Method Transfer

Background

Analytical method transfer is a critical step when moving analytical procedures between laboratories, whether from development to quality control (QC), between manufacturing sites, or to external partners.

Methodology

Our method transfer services are designed to ensure consistency, reproducibility, and compliance across different testing environments. We follow a risk-based approach aligned with global standards such as USP<1224>, ensuring that transferred methods perform equivalently in the receiving laboratory. Key elements of our method transfer process include:

• Development of a detailed transfer protocol
• Comparative testing between sending and receiving laboratories
• Co-validation or verification strategies when necessary
• Investigation and resolution of deviations

By leveraging advanced instrumentation and standardized procedures, we ensure seamless knowledge transfer and minimize the risk of variability or data integrity issues.

Analytical Method Validation

Background

Analytical method validation confirms that a method is suitable for its intended purpose and meets regulatory requirements. It is a mandatory step for methods used in regulatory submissions, release testing, and stability studies.

Methodology

We perform validation studies in accordance with ICH Q2 (R1/R2), FDA, and global pharmacopeial guidelines, evaluating critical performance characteristics such as specificity, accuracy, precision, linearity, range, detection limits, quantitation limits, and robustness. Our validation strategy adopts a lifecycle approach, ensuring that methods remain reliable throughout their use. This includes both early-phase qualification and full validation for late-stage and commercial applications.

Deliverables include:

• Validation protocols with predefined acceptance criteria
• Comprehensive validation reports
• System suitability criteria
• Regulatory-ready documentation

Target Product / Molecule Type

Our analytical expertise spans a broad range of product types and molecular modalities, enabling us to support diverse pharmaceutical and biopharmaceutical pipelines. We provide services for:

Our methods are designed to evaluate not only APIs but also excipients, raw materials, degradation products, and finished dosage forms.

Instrumentation & Analytical Platforms

State-of-the-art instrumentation is essential for delivering high-quality analytical data. Our laboratories are equipped with a comprehensive suite of advanced analytical technologies, enabling us to address complex analytical challenges.

• High-performance liquid chromatography (HPLC)
• Ultra-performance liquid chromatography (UPLC)
• Gas chromatography (GC and Headspace GC)
• LC-MS/MS
• High-resolution mass spectrometry (HRMS)
• Nuclear magnetic resonance (NMR: ¹H, ¹³C, qNMR)
• UV/Vis spectroscopy
• FTIR and Raman spectroscopy
• Dissolution testing systems (USP Apparatus 1–4)
• Inductively coupled plasma mass spectrometry (ICP-MS)
• Particle size analysis and microscopy
• Ligand binding assays (LBA)
• ...

These platforms allow us to deliver high sensitivity, selectivity, and reproducibility, supporting both routine testing and complex method development challenges.

Our Advantages

• Deep Scientific Expertise: Our multidisciplinary team of analytical scientists brings extensive experience across a wide range of technologies, molecule types, and therapeutic areas. This expertise enables us to develop innovative solutions for even the most complex analytical challenges.
• Regulatory Excellence: We operate in full compliance with GLP, GMP, FDA, and ICH guidelines, ensuring that all data generated are audit-ready and suitable for regulatory submissions.
• Phase-Appropriate Strategies: We tailor our services to match your development stage, from early discovery to commercial manufacturing, ensuring efficiency, cost-effectiveness, and regulatory alignment.
• Advanced Technology Platform: Our investment in cutting-edge instrumentation allows us to deliver high-quality, reliable data with rapid turnaround times.
• End-to-End Support: From method development through transfer and validation, we provide a seamless, integrated service model that reduces complexity and accelerates timelines.
• Client-Centric Approach: We work closely with our clients to understand their specific needs, offering flexible, customized solutions and transparent communication throughout the project lifecycle.

Please kindly note that our services are for research use only.